Establishment of an erythroid cell line from primary CD36+ erythroid progenitor cells

Experimental Hematology

Volumn 38, Issue 11, 2010, Pages

  Wong, Susan ^a   Keyvanfar, Keyvan ^a   Wan, Zhihong ^a   Kajigaya, Sachiko ^a   Young, Neal S ^a   Zhi, Ning ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; HEMOGLOBIN; LENTIVIRUS VECTOR; PROTEIN E6; PROTEIN E7; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL TRANSFORMATION; COLONY FORMATION; COLONY FORMING CELL; CONTROLLED STUDY; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; GENE EXPRESSION PROFILING; GENETIC TRANSDUCTION; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPE; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL;

HUMAN PAPILLOMAVIRUS TYPE 16; LENTIVIRUS;

EID: 78649390198     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.07.012     Document Type: Article

References (52)

1. Febbraio M., Hajjar D.P., Silverstein R.L. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 2001, 108:785-791.
2. Okumura N., Tsuji K., Nakahata T. Changes in cell surface antigen expressions during proliferation and differentiation of human erythroid progenitors. Blood 1992, 80:642-650.
3. Wong S., Zhi N., Filippone C., et al. Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication. J Virol 2008, 82:2470-2476.
4. de Wolf J.T., Muller E.W., Hendriks D.H., Halie R.M., Vellenga E. Mast cell growth factor modulates CD36 antigen expression on erythroid progenitors from human bone marrow and peripheral blood associated with ongoing differentiation. Blood 1994, 84:59-64.
5. Edelman P., Vinci G., Villeval J.L., et al. A monoclonal antibody against an erythrocyte ontogenic antigen identifies fetal and adult erythroid progenitors. Blood 1986, 67:56-63.
6. Lozzio C.B., Lozzio B.B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975, 45:321-334.
7. Kishi K. A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. Leuk Res 1985, 9:381-390.
8. Okuno Y., Suzuki A., Ichiba S., et al. Establishment of an erythroid cell line (JK-1) that spontaneously differentiates to red cells. Cancer 1990, 66:1544-1551.
9. Okano H., Okamura J., Yagawa K., Tasaka H., Motomura S. Human erythroid cell lines derived from a patient with acute erythremia. J Cancer Res Clin Oncol 1981, 102:49-55.
10. Kitamura T., Tange T., Terasawa T., et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 1989, 140:323-334.
11. Martin P., Papayannopoulou T. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science 1982, 216:1233-1235.
12. Bonsi L., Grossi A., Strippoli P., et al. An erythroid and megakaryocytic common precursor cell line (B1647) expressing both c-mpl and erythropoietin receptor (Epo-R) proliferates and modifies globin chain synthesis in response to megakaryocyte growth and development factor (MGDF) but not to erythropoietin (Epo). Br J Haematol 1997, 98:549-559.
13. Morgan D.A., Gumucio D.L., Brodsky I. Granulocyte-macrophage colony-stimulating factor-dependent growth and erythropoietin-induced differentiation of a human cell line MB-02. Blood 1991, 78:2860-2871.
14. Avanzi G.C., Lista P., Giovinazzo B., et al. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Br J Haematol 1988, 69:359-366.
15. Komatsu N., Yamamoto M., Fujita H., et al. Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7. Blood 1993, 82:456-464.
16. Freyssinier J.M., Lecoq-Lafon C., Amsellem S., et al. Purification, amplification and characterization of a population of human erythroid progenitors. Br J Haematol 1999, 106:912-922.
17. Giarratana M.C., Kobari L., Lapillonne H., et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 2005, 23:69-74.
18. Wong S., Brown K.E. Development of an improved method of detection of infectious parvovirus B19. J Clin Virol 2006, 35:407-413.
19. Vousden K.H., Doniger J., DiPaolo J.A., Lowy D.R. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene. Oncogene Res 1988, 3:167-175.
20. Akimov S.S., Ramezani A., Hawley T.S., Hawley R.G. Bypass of senescence, immortalization, and transformation of human hematopoietic progenitor cells. Stem Cells 2005, 23:1423-1433.
21. Honma Y., Onozuka Y., Okabe-Kado J., Kasukabe T., Hozumi M. Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity. Cancer Res 1991, 51:4535-4538.
22. Baliga B.S., Mankad M., Shah A.K., Mankad V.N. Mechanism of differentiation of human erythroleukaemic cell line K562 by hemin. Cell Prolif 1993, 26:519-529.
23. Craston R., Koh M., McDermott A., Ray N., Prentice H.G., Lowdell M.W. Temporal dynamics of CD69 expression on lymphoid cells. J Immunol Methods 1997, 209:37-45.
24. Depraetere S., Vanhaesebroeck B., Fiers W., Willems J., Joniau M. Polar agents with differentiation inducing capacity potentiate tumor necrosis factor-mediated cytotoxicity in human myeloid cell lines. J Leukoc Biol 1995, 57:141-151.
25. Drexler H.G., Gaedicke G., Minowada J. Erythroleukemia cell lines HEL and K-562: changes in isoenzyme profiles and morphology during induction of differentiation. Hematol Oncol 1986, 4:163-174.
26. Komatsu N., Fujita H. Induced megakaryocytic maturation of the human leukemia cell line UT-7 results in down-modulation of erythropoietin receptor gene expression. Cancer Res 1993, 53:1156-1161.
27. Bodnar A.G., Ouellette M., Frolkis M., et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349-352.
28. Wieser M., Stadler G., Jennings P., et al. hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. Am J Physiol Renal Physiol 2008, 295:F1365-F1375.
29. Pellegrini G., Dellambra E., Paterna P., et al. Telomerase activity is sufficient to bypass replicative senescence in human limbal and conjunctival but not corneal keratinocytes. Eur J Cell Biol 2004, 83:691-700.
30. Kiyono T., Foster S.A., Koop J.I., McDougall J.K., Galloway D.A., Klingelhutz A.J. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998, 396:84-88.
31. Wise-Draper T.M., Wells S.I. Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci 2008, 13:1003-1017.
32. Jha K.K., Banga S., Palejwala V., Ozer H.L. SV40-Mediated immortalization. Exp Cell Res 1998, 245:1-7.
33. Zhang H., Jin Y., Chen X., et al. Cytogenetic aberrations in immortalization of esophageal epithelial cells. Cancer Genet Cytogenet 2006, 165:25-35.
34. Beausejour C.M., Krtolica A., Galimi F., et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 2003, 22:4212-4222.
35. Wei W., Sedivy J.M. Differentiation between senescence (M1) and crisis (M2) in human fibroblast cultures. Exp Cell Res 1999, 253:519-522.
36. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120:513-522.
37. Shay J.W., Van Der Haegen B.A., Ying Y., Wright W.E. The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp Cell Res 1993, 209:45-52.
38. White A.E., Livanos E.M., Tlsty T.D. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev 1994, 8:666-677.
39. Klingelhutz A.J., Qian Q., Phillips S.L., Gourronc F.A., Darbro B.W., Patil S.R. Amplification of the chromosome 20q region is associated with expression of HPV-16 E7 in human airway and anogenital epithelial cells. Virology 2005, 340:237-244.
40. Zhang L.P., Jiang J.K., Tam J.W., et al. Effects of Matrine on proliferation and differentiation in K-562 cells. Leuk Res 2001, 25:793-800.
41. Hooper W.C., Pruckler J., Jackson D., Evatt B.L. The synergistic effect of hemin and transforming growth factor-beta on hemoglobin accumulation in HEL erythroleukemia cells. Leuk Res 1991, 15:753-758.
42. Chretien S., Varlet P., Verdier F., et al. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation. EMBO J 1996, 15:4174-4181.
43. Minegishi N., Minegishi M., Tsuchiya S., et al. Erythropoietin-dependent induction of hemoglobin synthesis in a cytokine-dependent cell line M-TAT. J Biol Chem 1994, 269:27700-27704.
44. Tsuyuoka R., Takahashi T., Suzuki A., et al. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles. Stem Cells 1995, 13:54-64.
45. Fibach E., Kollia P., Schechter A.N., Noguchi C.T., Rodgers G.P. Hemin-induced acceleration of hemoglobin production in immature cultured erythroid cells: preferential enhancement of fetal hemoglobin. Blood 1995, 85:2967-2974.
46. Rutherford T., Clegg J.B., Higgs D.R., Jones R.W., Thompson J., Weatherall D.J. Embryonic erythroid differentiation in the human leukemic cell line K562. Proc Natl Acad Sci U S A 1981, 78:348-352.
47. Shaffer A.L., Emre N.C., Lamy L., et al. IRF4 addiction in multiple myeloma. Nature 2008, 454:226-231.
48. Hsi E.D., Sup S.J., Alemany C., et al. MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis. Am J Clin Pathol 2006, 125:776-782.
49. Copie-Bergman C., Plonquet A., Alonso M.A., et al. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas. Mod Pathol 2002, 15:1172-1180.
50. Gubin A.N., Njoroge J.M., Bouffard G.G., Miller J.L. Gene expression in proliferating human erythroid cells. Genomics 1999, 59:168-177.
51. Dolznig H., Boulme F., Stangl K., et al. Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arrays. FASEB J 2001, 15:1442-1444.
52. Kolbus A., Blazquez-Domingo M., Carotta S., et al. Cooperative signaling between cytokine receptors and the glucocorticoid receptor in the expansion of erythroid progenitors: molecular analysis by expression profiling. Blood 2003, 102:3136-3146.